Can Omega-3 Help Relieve Eczema Symptoms?

Omega-3 fatty acids show real biological activity against the kind of inflammation that drives eczema, and a handful of small clinical trials have reported meaningful symptom improvements. But the honest picture is messier than supplement labels suggest. The most authoritative review of the evidence, a Cochrane systematic review, found only a “possible modest benefit” from fish oil and called for much larger, well-designed trials before the results should change clinical practice. So the answer is a qualified maybe, with some genuinely encouraging signals buried inside a frustratingly thin evidence base.

Why Omega-3s Are Biologically Plausible for Eczema

Eczema, or atopic dermatitis, is driven by two intertwined problems: the skin barrier doesn’t hold together properly, and the immune system overreacts to things it shouldn’t. Certain immune pathways ramp up the production of inflammatory signaling molecules, which in turn make the barrier even leakier, which lets in more irritants, which provokes more inflammation. It’s a self-reinforcing cycle.

Omega-3 fatty acids, particularly EPA and DHA found in fish and marine oils, have well-documented anti-inflammatory properties across many organ systems. In the skin specifically, these fats and their breakdown products can dampen the inflammatory response triggered by various stressors and help maintain skin health.¹ EPA, for example, has been shown to reduce the activity of T cells (a type of immune cell heavily involved in eczema flares) and to dial down delayed-type immune reactions in the skin.² Beyond calming inflammation, omega-3s appear to support the skin’s moisture barrier. In pilot studies of healthy adults, krill oil supplements improved skin hydration, elasticity, and reduced water loss through the skin, and these improvements tracked directly with increases in the participants’ omega-3 levels.³

So the theory is sound: eczema involves barrier dysfunction and runaway inflammation, and omega-3s can address both. The question is whether swallowing a capsule or eating more salmon translates into noticeably better skin in people who actually have the condition.

What Clinical Trials Show in Adults

The trial data for adults with eczema is limited but not empty. In one randomized, double-blind trial, 21 adults aged 18 to 40 with eczema took high-dose DHA (about 5,400 mg per day) for eight weeks, while a control group took saturated fatty acid capsules. The DHA group saw their blood omega-3 levels rise significantly, their ratio of inflammatory omega-6 to omega-3 fats improve, and their eczema severity scores drop compared to where they started.⁴ That’s encouraging, but the study was small, and the DHA dose was far higher than what most commercial supplements provide.

The Cochrane systematic review, which represents the gold standard for synthesizing clinical evidence, looked across all dietary supplements tested for established eczema. On fish oil specifically, it identified two small studies that hinted at a modest benefit but noted that many outcomes were explored in those trials, raising the risk that positive results could be statistical noise. The review’s conclusion was blunt: a convincingly positive result from a much larger study with a pre-registered protocol is needed before fish oil should influence clinical practice.⁵

That assessment hasn’t changed as of the most recent update. No large, rigorously designed trial of omega-3 supplementation for adult eczema has been published. The studies that exist are underpowered, meaning they enrolled too few people to detect anything smaller than a dramatic effect. Dermatologists who follow this literature tend to describe omega-3s as a reasonable add-on that probably won’t hurt and might help, rather than as a proven treatment.

Stronger Signals in Children

The pediatric evidence is a bit more compelling. A randomized, triple-blind trial gave children with atopic dermatitis either EPA supplements or a placebo alongside their usual care. After just two weeks, the children taking EPA had significantly lower eczema severity scores. By four weeks, the gap was even wider, and the EPA group needed corticosteroid treatment at roughly half the rate of the placebo group.⁶ That finding is worth paying attention to because reducing steroid dependence is a real, practical goal for parents managing a child’s eczema.

Separately, a cross-sectional analysis of dietary data from children and adolescents found that higher total omega-3 intake was associated with lower odds of having eczema. The association was modest but statistically meaningful, with roughly a 12 to 16 percent reduction in eczema risk for each increment of omega-3 consumed.⁷ Observational data like this can’t prove that the omega-3s caused the protection, but it fits the pattern.

One of the more practical findings in the pediatric literature comes from a large cohort study that tracked children’s diets and later health outcomes. Children who ate any fish at age one had a lower prevalence of eczema, asthma, and wheeze when they were six years old.⁸ This suggests that early exposure to omega-3-rich foods during a critical window of immune development could have lasting effects, though it’s also possible that families who introduce fish early differ from those who don’t in ways the researchers couldn’t fully account for.

The Complicated Prenatal Story

If omega-3s help calm eczema-related inflammation, could giving them to pregnant women protect the baby from developing eczema in the first place? Several research groups have tested this idea, and the results are genuinely contradictory.

Some trials found benefits. In one study, infants born to mothers who took omega-3 supplements during pregnancy had lower rates of eczema at 12 months (about 8 percent versus 24 percent in the control group) and were far less likely to have severe eczema.⁹ Those are large differences. But another trial found the opposite: children whose mothers took EPA or DHA during pregnancy had a five-fold or greater increased risk of eczema at 36 months compared to the placebo group, a result that persisted even after adjusting for other risk factors like family history.¹⁰

When you pool the prenatal trials together, the contradictions average out to nothing. A systematic review and meta-analysis of five randomized trials of omega-3 supplementation during pregnancy found no significant effect on the child’s risk of developing eczema or atopic dermatitis.¹¹ The fact that individual trials swung so dramatically in opposite directions, while the overall signal washed out, tells you that there are probably factors at play, such as the dose used, the timing of supplementation, or the genetic background of the mother and child, that determine whether prenatal omega-3s help, hurt, or do nothing for eczema risk.

Why Genetics May Explain the Inconsistency

One of the more interesting threads in this research is the role of genetics in how your body processes omega-3 fats. A cluster of genes called FADS1 and FADS2 controls the enzymes that convert dietary fatty acids into their active forms. Variations in these genes influence how efficiently you turn the omega-3s in your food or supplements into the EPA and DHA that actually do the anti-inflammatory work.

A Mendelian randomization study, which uses genetic variants as a natural experiment to test causal relationships, found that genetically higher omega-3 levels were linked to modestly lower odds of atopic dermatitis. The effect appeared to be driven largely by a single genetic variant (rs174546) in the FADS gene cluster, suggesting that the pathway by which your body processes these fats matters as much as how much you consume.¹²

The genetics get more nuanced the closer you look. Another Mendelian randomization study found that higher expression of FADS1 in skin fibroblasts was associated with reduced atopic dermatitis risk, while higher expression of a related enzyme, FADS2, in skin tissue was associated with increased risk.¹³ In plain terms, the same family of genes that help you metabolize omega-3s can either protect against or promote eczema depending on which specific enzyme is more active and in what tissue. This may partly explain why some people with eczema seem to improve on omega-3 supplements while others see no change or even get worse.

An earlier study in children yielded similarly mixed signals: in one cohort, variants in the FADS gene cluster roughly doubled or quadrupled eczema risk, while in a second cohort, the same variants showed no association whatsoever.¹⁴ This kind of inconsistency across populations is a hallmark of gene-environment interactions where diet, microbiome composition, or other exposures modify the effect of a genetic variant.

Practical Considerations if You Want to Try It

If you have eczema and want to give omega-3s a shot, here’s what the research can tell you about doing it sensibly.

Doses in the trials that showed benefits were generally higher than what a standard fish oil capsule delivers. One pediatric trial used a daily product containing 600 mg of EPA and 400 mg of DHA.¹⁵ The adult trial that found improvements used roughly 5,400 mg of DHA daily, which is exceptionally high and would require a large number of standard capsules.¹⁶ A typical over-the-counter fish oil capsule contains around 300 mg of combined EPA and DHA, so you’d need to pay attention to the label and possibly take concentrated formulations to reach the doses used in research.

Supplement quality matters more than many consumers realize. Fish oil oxidizes over time, and oxidized oil may not only lose its benefits but could irritate cells. A laboratory analysis of commercially available fish oil supplements found that while most met international quality standards for oxidation, a few exceeded the limits, and some showed dose-dependent inhibitory effects on skin cell growth in the lab.¹⁷ Storing supplements in a cool place, checking expiration dates, and choosing products from manufacturers that test for oxidation markers are all reasonable precautions.

Side effects at moderate doses are generally mild: fishy aftertaste, minor digestive discomfort, and occasionally loose stools. At very high doses, omega-3s can thin the blood slightly, so anyone on anticoagulant medication should discuss supplementation with their doctor. The pediatric trial described EPA as “well-tolerated” with no serious adverse events reported.

If swallowing capsules isn’t appealing, eating fatty fish two to three times per week is another way to boost omega-3 intake. Salmon, mackerel, sardines, and herring are among the richest sources. As noted earlier, early introduction of fish in a child’s diet has been associated with lower rates of eczema later in childhood, though whether this reflects the omega-3 content specifically or something else about fish consumption remains unclear.

Omega-3s Versus Standard Eczema Treatments

Nothing in the current evidence suggests omega-3 supplements should replace the standard approaches to eczema management, which include regular moisturizing to repair the skin barrier, topical corticosteroids or calcineurin inhibitors for flares, and trigger avoidance. The clinical trials that showed benefits from omega-3s generally tested them as add-ons to conventional treatment, not as replacements. The pediatric EPA trial, for example, measured how many children needed to go back on corticosteroids; the supplement didn’t eliminate that need, it reduced it.

Where omega-3s may earn a role is in the category of supportive, low-risk strategies that patients stack alongside their prescribed regimen. If someone is already doing the basics well and still dealing with chronic low-grade flares, adding a high-quality omega-3 supplement at a meaningful dose is unlikely to cause problems and has some chance of making things modestly better. That’s a reasonable bar for something available without a prescription, even if the evidence falls short of the bar set for approved medications.

Topical Omega-3s and the Skin Barrier

Most of the eczema research has focused on oral supplements, but there’s a small body of work on applying omega-3-containing formulations directly to the skin. In a small trial with healthy volunteers, a cream containing an omega-3 derivative improved skin hydration by about 58 percent compared to a vehicle cream after 24 hours, while also reducing water loss through the skin.¹⁸ That was tested on normal skin, not eczema-affected skin, so extrapolating to people with a compromised barrier requires caution. Still, given that dryness and barrier dysfunction are core features of eczema, topical formulations that deliver omega-3s directly to where they’re needed represent an intriguing research direction.

The challenge with topical delivery is formulation stability. Omega-3 fatty acids oxidize rapidly when exposed to air and light, which is why fish oil capsules are sealed and sometimes contain antioxidants like vitamin E. Incorporating these fats into a cream or ointment that remains stable on a shelf, penetrates the skin effectively, and reaches the deeper layers where inflammation occurs is a nontrivial formulation problem. A systematic review on topical omega-3 use noted that DHA and EPA can reduce inflammation in skin exposed to various stressors, but most of the evidence comes from lab models and very early-stage human testing rather than from trials in eczema patients.¹

The Omega-6 Connection

Omega-3s don’t operate in isolation. They compete with omega-6 fatty acids for the same metabolic enzymes, and the ratio between these two fat families in your body influences the balance between pro-inflammatory and anti-inflammatory signals. Modern Western diets tend to be heavily skewed toward omega-6 fats, found abundantly in vegetable oils, processed foods, and grain-fed animal products. Some researchers have argued that this dietary imbalance contributes to the rising prevalence of inflammatory conditions including eczema, and that increasing omega-3 intake may work partly by restoring a healthier ratio rather than through any single anti-inflammatory mechanism.

The adult eczema trial that used high-dose DHA found that the omega-6-to-omega-3 ratio in participants’ blood dropped significantly during supplementation, and this shift correlated with clinical improvement.⁴ This raises the possibility that for some people, reducing omega-6 intake from highly processed foods could complement omega-3 supplementation. Whether dietary omega-6 reduction alone would help eczema hasn’t been well tested, but the biochemical logic supports the idea that both sides of the ratio matter.

Gamma-linolenic acid (GLA), an omega-6 fat found in evening primrose oil and borage oil, has itself been studied for eczema with similarly inconclusive results. Some combined supplement formulations include GLA alongside EPA and DHA, as one pediatric product did with 10 mg of GLA.¹⁵ The rationale is that GLA feeds into anti-inflammatory pathways distinct from those used by EPA and DHA, though evidence that combination supplements outperform omega-3s alone is sparse.